CN1064541C - Medicine for treating gynecological chronic inflammation - Google Patents

Medicine for treating gynecological chronic inflammation Download PDF

Info

Publication number
CN1064541C
CN1064541C CN97101728A CN97101728A CN1064541C CN 1064541 C CN1064541 C CN 1064541C CN 97101728 A CN97101728 A CN 97101728A CN 97101728 A CN97101728 A CN 97101728A CN 1064541 C CN1064541 C CN 1064541C
Authority
CN
China
Prior art keywords
blood
radix
medicine
chronic inflammation
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97101728A
Other languages
Chinese (zh)
Other versions
CN1192362A (en
Inventor
何新顺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97101728A priority Critical patent/CN1064541C/en
Publication of CN1192362A publication Critical patent/CN1192362A/en
Application granted granted Critical
Publication of CN1064541C publication Critical patent/CN1064541C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a medicine for treating gynecological chronic inflammation, which comprises the following protobionts of traditional Chinese medicines: astragalin, common pratia fruit phenol, a plant amino acid, flavonoid, isoflavone, nitidine, angelica volatilization oil, etc. The medicine of the present invention is respectively made into capsules, tablets and oral medicinal liquids in the form of 100% of pure Chinese herb preparation, and has the functions of regulating qi and blood, tonifying the blood, nourishing the face, activating blood circulation to dissipate blood stasis, diminishing inflammation, alleviating pain, and stopping leukorrhagia by constringency; the present invention can be used for various symptoms of blood vacuity and blood stasis caused by gynecological chronic inflammation.

Description

A kind of medicine for the treatment of female chronic inflammation
The present invention relates to a kind of medicine for the treatment of female chronic inflammation, and the medicine of said preparation is formed and making.
Female chronic inflammation is that a kind of deficiency and excess is held the miscellaneous diseases card under the arm, and its disorder of QI and blood is one of important mechanism of gynaecopathia.The women is owing to secular menstruation, and gestation, childbirth, suckling or intemperate sexual intercourse, causes cloudy blood consume easily, forms blood deficiency.Owing to vim and vigour are that money is given birth to and depended on each other for existence mutually, and qi being the governor of blood, blood being the material foundation of QI, so blood deficiency causes the deficiency of vital energy easily, it is unable that the deficiency of vital energy is then transported blood, the blood walking retardation in children is delayed stagnation and the hyperamization stasis of blood; Blood deficiency is then easily experienced pathogen.Owing among the blood deficiency deficiency of vital energy and the evil resistance born of the same parents, cause stasis of blood resistance easily, stagnation of QI and blood may bring about pain.Because top these etiology and pathogenesis cause menoxenia, inferior belly gas pain, the performance of chronic gynecological inflammation such as leucorrhoea grow in quantity.Chronic gynecological inflammation is women's a commonly encountered diseases, frequently-occurring disease.But now medicine exists and takes effect slowly, and curative effect is not remarkable, or shortcoming such as side effect is big.
The present invention is according to traditional theory, and the women is this and qi being the governor of blood with blood, blood being the material foundation of QI, and weakened body resistance then heresy is invaded, and causes the evil resistance of holding concurrently of women's Qi stagnation blood stasis to be mark easily, and is real in the blood deficiency deficiency of vital energy be this principle prescription, discusses the characteristics of controlling to give prominence to differential diagnosis in tcm.The present invention is based on the anti inflammatory blood quickening of enriching blood, the QI invigorating convergence, and promoting the circulation of QI to relieve pain are auxilliary, make a kind of pharmaceutical preparation of treatment female chronic inflammation evident in efficacy.
The present invention it have safety good, and specificity is good, the sensitivity height, and practicality is big, the advantage that feasibility is good.
The present invention can concentrate effective ingredient and the performance property of medicine and performance synergism separately with the extraction of new and high technology to the Chinese medicine ultimate constituent, makes the curative effect of this medicine bigger.
The purpose of this invention is to provide a kind of drug compound preparation for the treatment of female chronic inflammation, and the composition of this compound medicine is provided and has extracted compound method.
It is as follows that medicine of the present invention is formed the weight proportion raw material:
The Radix Astragali 8% Herba Melastomatis dodecandri root 30% Caulis Spatholobi 23%
Radix Zanthoxyli 11% Radix Angelicae Sinensis 9% Herba Fici Simplicissimae 6%
Radix Bupleuri 4% Herba Hedyotidis Diffusae 9%
Method for making:
Embodiment 1:
Get the full dose in the Radix Astragali in the above-mentioned weight proportion raw material, Herba Melastomatis dodecandri root, Caulis Spatholobi, Radix Zanthoxyli, Herba Fici Simplicissimae, the Herba Hedyotidis Diffusae, get Radix Bupleuri and work as and be classified as 50% of full dose, place in the multi-function extractor, extract 2 times, each 2 hours, merging filtrate, be condensed into thick paste, and add 5% starch and make absorbent, put in the drying baker, cold drying, and with other 50% Radix Angelicae Sinensis and Radix Bupleuri cold drying in the full dose, crushing screening 100 orders are mixed medicine and dried cream then, after infrared sterilization, sterilization, incapsulate promptly.This law also can be packaged into electuary.
Embodiment 2:
Get the full dose in the Radix Astragali in the above-mentioned weight proportion raw material, Herba Melastomatis dodecandri root, Caulis Spatholobi, Radix Zanthoxyli, Herba Fici Simplicissimae, Radix Bupleuri, the Herba Hedyotidis Diffusae, get when being classified as 50% in the full dose, said medicine is extracted dried cream, with 100 orders that sieve of other 50% Radix Angelicae Sinensis drying and crushing in the full dose, with whole medicine mixings, granulate the low-temperature reduced-pressure drying with low-concentration ethanol, granulate adds an amount of magnesium stearate tabletting, and sugar coating promptly.
Embodiment 3:
The Radix Astragali, Herba Melastomatis dodecandri root, Caulis Spatholobi, Radix Zanthoxyli, Herba Fici Simplicissimae, the Herba Hedyotidis Diffusae of getting in the above-mentioned weight proportion raw material are put in the extraction pot, boil and carry 2 times, each 2 hours, other gets Radix Angelicae Sinensis, radix bupleuri extract volatile oil, and merging filtrate filters, and puts cold back and separates with centrifuge, remove precipitate, taking liquid is made into debita spissitudo, goes into gland with coloured glass bottle is canned, and autoclaving promptly gets and props up dress or bottled oral liquid.
The present invention is through clinical practice, and effect is remarkable, and effective percentage reaches more than 95%, is the safe and reliable good prescription that has no side effect of treatment female chronic inflammation.

Claims (2)

1, a kind of medicine for the treatment of female chronic inflammation is characterized in that it is made by the following weight proportion raw material:
The Radix Astragali 8% Herba Melastomatis dodecandri root 30% Caulis Spatholobi 23%
Radix Zanthoxyli 11% Radix Angelicae Sinensis 9% Herba Fici Simplicissimae 6%
Radix Bupleuri 4% Herba Hedyotidis Diffusae 9%
2, the preparation method of medicine as claimed in claim 1, it is characterized in that: the Radix Astragali, Herba Melastomatis dodecandri root, Caulis Spatholobi, Radix Zanthoxyli, Radix Angelicae Sinensis, Herba Fici Simplicissimae and the Radix Angelicae Sinensis and the Radix Bupleuri water that account for full dose 50% are carried, the Radix Angelicae Sinensis of second half amount and Radix Bupleuri are ground into powder, mixing, make medicament.Can make oral capsule, electuary, a sugar coated tablet and bottle dress oral liquid respectively.
CN97101728A 1997-01-19 1997-01-19 Medicine for treating gynecological chronic inflammation Expired - Fee Related CN1064541C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97101728A CN1064541C (en) 1997-01-19 1997-01-19 Medicine for treating gynecological chronic inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97101728A CN1064541C (en) 1997-01-19 1997-01-19 Medicine for treating gynecological chronic inflammation

Publications (2)

Publication Number Publication Date
CN1192362A CN1192362A (en) 1998-09-09
CN1064541C true CN1064541C (en) 2001-04-18

Family

ID=5165946

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97101728A Expired - Fee Related CN1064541C (en) 1997-01-19 1997-01-19 Medicine for treating gynecological chronic inflammation

Country Status (1)

Country Link
CN (1) CN1064541C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110404031A (en) * 2019-07-29 2019-11-05 淄博蓝丝带健康管理有限公司 A kind of Traditional Chinese medicine bath powder for women and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1091308A (en) * 1993-02-22 1994-08-31 高景树 A kind of " Fukangling " medicine for treatment of gynecopathy for the treatment of common gynecological disease and preparation method thereof
CN1091965A (en) * 1993-03-08 1994-09-14 程小玲 Woman's inflammation disappears

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1091308A (en) * 1993-02-22 1994-08-31 高景树 A kind of " Fukangling " medicine for treatment of gynecopathy for the treatment of common gynecological disease and preparation method thereof
CN1091965A (en) * 1993-03-08 1994-09-14 程小玲 Woman's inflammation disappears

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
《中成药》15(9) 1993.9.30 何玉文等,盆腔消炎片332例临床观察总结 *
《陕西中医》8(8) 1987.8.31 吕兰薰,抗炎中药的研究动态 *
《陕西中医》8(8) 1987.8.31 吕兰薰,抗炎中药的研究动态;《中成药》15(9) 1993.9.30 何玉文等,盆腔消炎片332例临床观察总结 *

Also Published As

Publication number Publication date
CN1192362A (en) 1998-09-09

Similar Documents

Publication Publication Date Title
CN1057451C (en) Children coryza medicine and preparing method
CN102165983B (en) Mixed herb tea
CN101433654B (en) Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof
CN103341052A (en) Medicine for preventing and treating hypertension, hyperlipidemia, hyperglycemia and hypotension and preparation method thereof
CN100396328C (en) Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny
CN101011544A (en) Gout rapid recovery pill(capsule) and preparation technique thereof
CN102784366B (en) Medical composition with function of decanting and protecting liver
CN102416145B (en) Chinese medicinal composition for treating menstrual disorder
CN103893593B (en) Pharmaceutical composition with effects of clearing away heat and toxic materials, resisting inflammations and boosting immunity
CN105232957A (en) Traditional Chinese medicine decoction for treating excess heat syndrome swollen sore throat
CN102145121A (en) Chinese medical preparation assisting to adjusting blood sugar
CN1064541C (en) Medicine for treating gynecological chronic inflammation
CN102579677B (en) Chinese medicinal composition for treating brain glioma
CN101628052A (en) Medicinal composition used for treating constipation and preparation method thereof
CN1418693A (en) Oral liquid medicine for treating stomach-pain, and its prepn. method
CN108721557B (en) Traditional Chinese medicine composition with auxiliary protection function on gastric mucosa injury and preparation method and application thereof
CN1517115A (en) Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation
CN102218131B (en) External Chinese herbal medicine composition for promoting tissue regeneration and knitting bones
CN101850071A (en) Chinese medicament for treating chronic nephritis
CN111643561A (en) A Chinese medicinal composition for treating menoxenia, dysmenorrhea, and amenorrhea
CN108542979A (en) A kind of natural herb flowers tea-drinking of speckle removing, acne removing beautifying face and moistering lotion
CN1242779C (en) Liver disease treating and liver clearing Chinese traditional medicine
CN1047508C (en) Compound heathy gynostemma pentaphyllum drink
CN101843825B (en) Chinese medicament for treating climacteric syndromes
CN101085179A (en) Traditional Chinese medicine preparation for treating uremia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1036516

Country of ref document: HK